GeneDx Holdings Corp.WGSNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
1.55%
↑ 102% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-68.29%
Historical baseline
PeriodValueYoY Change
TTM1.55%+475.7%
2024-0.41%+99.4%
2023-67.37%+60.3%
2022-169.67%-63.1%
2021-104.03%+17.9%
2020-126.66%-1003.7%
2019-11.48%-